Topical ampicillin in the prevention of wound infection after appendicectomy. 1974

T Bates, and R H Down, and M C Houghton, and G J Lloyd

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007902 Length of Stay The period of confinement of a patient to a hospital or other health facility. Hospital Stay,Hospital Stays,Stay Length,Stay Lengths,Stay, Hospital,Stays, Hospital
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010538 Peritonitis INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. Primary Peritonitis,Secondary Peritonitis,Peritonitis, Primary,Peritonitis, Secondary
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004322 Drainage The removal of fluids or discharges from the body, such as from a wound, sore, or cavity.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations

Related Publications

T Bates, and R H Down, and M C Houghton, and G J Lloyd
February 1973, Lancet (London, England),
T Bates, and R H Down, and M C Houghton, and G J Lloyd
October 1969, British medical journal,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
August 1972, Annals of surgery,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
May 1970, Lancet (London, England),
T Bates, and R H Down, and M C Houghton, and G J Lloyd
March 1989, The British journal of surgery,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
May 1973, The British journal of surgery,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
March 1970, The British journal of clinical practice,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
May 1975, The British journal of clinical practice,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
February 1967, British medical journal,
T Bates, and R H Down, and M C Houghton, and G J Lloyd
March 1985, Ugeskrift for laeger,
Copied contents to your clipboard!